C-Path device director
This article was originally published in The Gray Sheet
Executive Summary
Ellen Feigal, MD, has been appointed director of medical devices and imaging of the Critical Path Institute (C-Path) in Tucson, Ariz., announced April 24. C-Path is a partner to FDA's Critical Path initiative to speed drugs, devices and diagnostics to market (1"The Gray Sheet" March 27, 2006, p. 5). Feigal worked at the National Cancer Institute from 1992 to 2004, where she spent her last three years as director of the Division of Cancer Treatment and Diagnostics. Currently, she is on sabbatical from the personalized medicine-focused Translational Genomics Research Institute (TGen), where she is VP-clinical sciences and deputy scientific director. Additionally, Jeffrey Cossman, MD, was appointed as C-Path's chief scientific officer April 18. Cosson has served as a senior scientist at the National Cancer Institute and the National Institutes of Health, and most recently was VP and medical director at genomics company Gene Logic...